Management of Hypertrophic scars and keloid

Keloidal scarring is one of the most frustrating clinical problems in wound healing. Keloids form following dermal injury and exhibit exuberant, indefinite growth of collagen .They tend to occur in darker skinned individuals with a familial tendency and not in the extremes of age. Keloid formation has been ascribed to altered growth factor regulation, aberrant collagen turnover, genetics, immune dysfunction, sebum reaction, and altered mechanics. No single unifying hypothesis adequately explains keloid formation.

 

KELOID VERSUS HYPERTROPHIC SCAR

Keloids and hypertrophic scars are separate clinical and histochemical entities. Clinically, hypertrophic scars remain within the confines of the original scar border, whereas keloids invade adjacent normal dermis. Hypertrophic scars generally arise within 4 weeks, grow intensely for several months, and then regress. In contrast, keloids may appear later following the initial scar and then gradually proliferate indefinitely. Although both keloids and hypertrophic scars show increased fibroblast density, only keloids have increased fibroblast proliferation rates.Collagen fibers in keloids are larger, thicker, and more wavy than those found in hypertrophic or normal scars and assume a random orientation, whereas those in hypertrophic scars orient parallel to the epidermal surface.

Hypertrophic-Scars-on-hand

Hypertrophic scar

Keloid

Keloid

Prevention

The initial surgical debridement must be carried out during the  first few hours after the moment of injury. The goal of such surgical debridement is to stop hemorrhage, remove any extraneous matter from the wound,  fix and immobilize the wound edges, take preventive measures to  fix edema, and stop any septic inflammation.   As a rule , the delayed     initial surgical     debridement results in formation     of hypertrophic and keloid scars .

Inadequate immobilization of the scar region or lack of  fixation results in continuous movement of the wound edges in all three planes: vertical, horizontal and sagittal. Eventually, the edges of the scar start spreading, and the bottom of scar begins to sag; a defect is formed that is to be “patched” by the skin. This leads to proliferation of  fibroblasts in the scar region and to intensification of collagen synthesis. This process results in formation of a hypertrophic or keloid scar.

In case of introduction of irritating materials or surface active materials to the wound or in case of protracted contact of such materials with the wound, such active substances create a focus of chronic inflammation in the region of scar formation. Because of this chronic inflammation, the duration of scar cicatrization and maturation increases. Therefore, hypertrophic scars are formed. Keloids are frequently formed in the course of tattooing. In this case, a pigment functions as an irritating agent; however, relevant trauma plays the leading role in this process.

 

keloid

Cryotherapy

Cryosurgery is successfully used for treatment and correction of hypertrophic scars and keloids.

The  first method (“application method)  is implemented by means of contact in fluence. In the  first stage, the cryogenic agent cools the special metal tip (Cryosurgical Closed Probes), which ensures freezing of the tissue. To carry out this procedure, special Cryosurgical Closed Probes of various forms and dimensions are used.

The second method (“open spray method”) freezes with the help of spraying. The cryogenic agent, after vaporization, is directed to the tissue in the form of a thin gaseous spray and freezes it.

The third method (“reed method”) is based on the utilization of a cotton wool or gauze swab, which is closely turned around a wooden stick and moistened in liquid nitrogen.

The reed method and open spray method are not used in the course of treatment and correction of keloids as they cannot create the necessary compression and prolonged exposure of the continuously low temperature. Such tissue processing results in the increase of activity of  fibroblasts instead of the destruction of  fibroblasts; collagen synthesis is increased by two to three times, and the scar continues to grow. Therefore, only one method may be utilized for the treatment of keloids: cryoapplication by the use of Cryosurgical Closed Probes.

Cryodestruction is implemented using Cryosurgical Closed Probes for two to three cryocycles, 20–40 s each . After several days, a crust forms on the treated surface. After removal of the crust, the scar mass decreases. This procedure is to be repeated after 3–4 weeks. To obtain an obvious result, it is necessary to carry out eight to ten procedures (as a minimum)

Contraindications, Side Effects, Complications

Contraindications  to cryodestruction treatment are cold urticaria and the low pain limit.

The main   side effects  of cryodestruction treatment are skin atrophy and depigmentation .  Melanocytes are situated more superficially than the  fibroblasts and the collagen  fi bers; therefore, they are the  first to die off.  Keloid treatment used as a single treatment method results in 51–84 % recrudescence; hence, it is applied in combination with other methods.  The hypertrophic scars respond to treatment much better: They require a shorter exposition period (15–30 s), fewer cryocycles, and fewer repeated procedures (as a rule, three to four procedures applied at a time interval of 3–4 weeks is enough). A positive result is observed in 75–85 % of treatment cases.

 

  Corticosteroid  Injections

Triamcinolone inhibits the proliferation of normal and keloid fibroblasts, inhibits collagen synthesis, increases collagenase production, and reduces levels of collagenase inhibitors. Typically 10 mg per linear centimeter of keloid every 2 to 6 weeks, until clinical resolution or until side effects prohibit use.
A suspension (crystalline) of 40 mg/ml triamcinolone acetonid or betamethasone sodium phosphate is used for intralesional injections. The maximal single dose for children ages 8–10 years is equal to 20 mg (beginning at 18 years, the dose is equal to 40 mg).

Contraindications to injection 

Absolute: oncological diseases, pregnancy, lactation, and breast-feeding.

Relative: kidney disease (pyelonephritis, glomerulonephritis); gastric ulcer and duodenal ulcer in the period of disease exacerbation.

Procedure

This suspension is to be diluted with water for injections or with 2 % lidocaine hydrochloride injection. A 1- to 2-ml syringe and 27- to 30-G needle are used for such injections. The needle is introduced into the depth of the scar in the direction that must be as much parallel to the skin surface as possible. Injections are to be made from different points. To prevent atrophy of the skin, the needle bevel shall be directed upwards. The scar becomes lighter if the medicine is injected correctly . For prophylaxis of suprarenal gland atrophy, it is necessary to observe the interval between the Procedures; the duration of such intervals is equal to 4–6 weeks. A course of treatment lasts from several months to several years. A positive dynamics is observed in 85–90 % of cases. Recurrences after complete disappearance of a keloid are observed in 5–10 % of cases. After 2–5 years, recurrences occur in 1–3 % of cases.

Side Effects and Complications

After three to four injections, telangiectasias occur in almost 100 % of cases. They do not disappear simultaneously and completely and may be removed using a vascular laser (Pulsed Dye Laser   , 585-nm wavelength).

In the case of triamcinolone acetonid at high concentration (40 mg/ml) and shortening intervals between injections, xanthomas may be formed . Xanthomas can resolve independently, without any treatment, within 1 year .   Atrophy of the skin and hypopigmentation spots may disappear spontaneously without treatment after 6–12 months; however, they remain in most cases.

 

Surgical excision

Surgical excision of a hypertrophic scar gives satisfactory results.

Surgical excision of keloids by itself generally results in lesion recurrence. Surgical excision of keloids alone has consistently shown poor results, with recurrence rates of 40 to 100 percent.Simple excision is believed to stimulate additional collagen synthesis,resulting in rapid regrowth and often a larger keloid. Surgical excision of a keloid scar as a single method without another method causes a relapse in 85–100 % of cases . Therefore, surgical excision used as a single method of treatment should not be applied. Nevertheless, there are cases when it is impossible to avoid surgical excision (in case of keloids on joints and the neck involving the formation of contractures).    During the postoperative period, the scar is treated as a potential keloid, involving the application of a number of treatments: corticosteroids, compression therapy, silicone sheeting and gels, and so on.

Subtotal excision along with lateral undermining has been credited with improved outcome and fewer recurrences . Because the rim of the keloid scar serves to splint the wound and relieve tension, the stimulus for collagen synthesis is decreased.

Surgical excisions can be closed either primarily or through a number of reconstructive techniques. In general, sutures are removed as early as possible and intradermal, subcuticular closure is preferred, to avoid suturemarks that subsequently develop keloids. Monofilamentous suture is preferred to braided suture to minimize local inflam-
matory reaction.If primary closure does not suffice, the wound from the surgical excision of keloids can be closed with flap advancement, autograft.

Relapse Prevention Measures

  1. It is necessary to apply conservative therapy prior to surgical excision; this therapy will include corticosteroid injections, x-ray therapy, and cryodestruction.
  2. Wound  closure  is  planned  precisely  with  minimum  tension in parallel with RSTLs.
  3. If  necessary,  use  deep  adaptation  stitching  for  layer specific closure and decreased stretch tension in the wound area.
  4. Apply  pressure  bands  and  compression  underwear  in  the early stages of the postoperative period.
  5. Intramarginal  corticosteroid  injections  into  the  wound  are made while the patient is on the surgical table.
  6. Postoperative radiation is to be started during the  first 24 h after the surgical operation. Total dose is no less than 12 Gy.
  7. Application  of  Imiquimod cream must be started the  first night after the surgical operation and continued for the following 8 weeks.
  8. During  the   first  year  after  surgical  operation,  visiting  a solarium or sauna or taking hot baths is not recommended because thermal procedures stimulate blood  flow in the scar area, which can provoke its growth.

Radiation

Radiation therapy effectively reduces keloid recurrence rates. Its use has been limited by the theoretical risk of inducing malignancy. Radiation therapy as an adjunct to keloid ex cision has efficacy rates of 65 to 99 percent in
long-term follow-up.Radiation of keloids damages the fibroblasts directly and affects collagen structure and
organization.

Silicone Sheets/Gel

Silicone containing substances    are mainly applied in the form of silicone sheeting or gels. Gels are applied on the face and neck and in the area of joints, where silicone sheeting cannot be  fixed. The silicone coatings do not affect the scar directly. The mechanism of their effect has not been investigated to its core, but the following scheme is assumed:   scar hydration  →   capillary compression  →   decreased level     of cytokine     delivery  →   decreased collagen     synthesis .

Use of silicone gel either as a topical gel or impregnated elastic sheet requires covering the entire scar for at least 12 hours each day, and ideally 24 hours per day except when the skin is being cleaned . Silicone gel can be used alone or as adjuvant therapy after excision and is effective after 4 to 6 months of treatment.

Adverse effects of silicone gel include occasional skin maceration, erosion, rash, and pruritus, all of which resolve with removal of the gel for several days followed by reapplication.

 

  Compression

Continuous compression of 20–40 mmHg is applied for 12–24 h/day for 3–12 months. On the one hand, it resists the scar tissue growth, holding it mechanically within the range of limited space; on the other, by putting pressure on the scar vessels, it blocks nutrition, which results in termination of growth or partial regression. Synthesis of collagen is an  oxygen-dependent process, as opposed to its dissociation. By forming local ischemia, we hamper collagen synthesis and maintain its disintegration (biodegradation).

Side effects

In the course of durable application, there may appear maceration, infection, folliculate, milia, and dermatitis. Introduction of durable compressions and the limitation in movement that results may provoke muscular atrophy when applied to children. In case of prolonged pressure on the joint areas, necrosis and osteoporosis of bones may form. All such complications are connected with the prolonged term of treatment.

  Laser

Laser therapy has been advocated but has not been shown to be effective in keloid management.
The carbon dioxide laser has the reported advantages of reduced blood loss, decreased post-operative pain, and less scarring. However, carbon dioxide laser excision alone yields unremarkable results, with over 50 percent recurrence
rate, suggesting no advantage over scalpel excision.

For treatment and correction of hypertrophic and keloid scars, the application of solely nonablative vascular laser is the most successful. In combination with silicone sheeting, the effect is fast and durable.

Treatment

  1. Three sessions of vascular laser at 585 nm. Treatment parameters: pulse duration 450   ms,   fluences  5.0–6.5  J/cm 2 spot 7 mm, session interval 6–8 weeks.
  2. Silicone  sheeting  for  12–14  h/day  for  3  months.

 

Derma abrasion

Microdermabrasion with hypertrophic scars does not give any substantially tangible results; hence, it does not descend below the dermal papillae. In the course of active keloid treatment it may even provoke keloid growth.

Rotation dermabrasion for hypertrophic scars gives positive results only with reiterative application; if applied to keloids, it may provoke their growth. Nevertheless, sandabrasion may be applied for the correction of old, inactive keloids. The procedure requires high accuracy and is applied until the  fi rst separate drops of blood appear.

Application of multiple procedures (six to eight with the interval of 1–1.5 months) results in decreased scar mass, increased elasticity, and decreased hyperpigmentation. However, the application of this method in the décolleté zone may provoke swelling and activation of the scar.

Sand abrasion is     performed by abrasive disks with sand bonded to their surface (as sandpaper). Depending on the grit size, different abrasive disks have different numbers (from No. 80 for the extra coarse to No. 240 for ultra fine). For facial scars, abrasion with 120- to 240-grit is to be applied. If the lesion does not go further than epidermis, super ficial dermabrasion is applied. In case of a deeper lesion (affecting the papillary layer), so-called deep dermabrasion is to be performed.

 

  5-Fluorouracil,  Bleomycin

Some cytostatic drugs are effective in the treatment of keloid and hypertrophic scars because of their ability to suppress cell proliferation.

Mode of action . The mode of action of these preparations is not sufficiently researched. 5-Fluorouracil is the antimetabolite of uracil and competes with it for thymidylate synthase. It blocks the synthesis of DNA cells, causing the formation of structurally imperfect RNA (by means of intrusion into its synthesis), which causes suppression of  fibroblast division.

Injection : Give a single intralesional injection of 50–100 mg of 5- fluorouracil per week. The course of treatment lasts for 8–12 weeks.

Side effects  and complications .

The main side effects of this treatment method are painful injections, hyperpigmentation, (hyperpigmentation is present in 100 % of cases); in rarer cases, there are scabs and ulceration. The intralesional injections of preparation cause much pain, sometimes to the extent that it complicates the therapy treatment.

Injection of equal quantity of 5 FU and corticosteroid gives the fastest results.

 

Dermaroller Collagen induction therapy

 

The dermaroller method is applied for treatment and correction of inactive keloids and hypertrophic scars in any region of the human body. In this case, depending on the thickness, prescription, and location of the scar, a dermaroller with needles from 0.5 to 2.5 mm long are used. Dermaroller’s microneedles penetrate into the skin up to the mesoderm and mechanically destroy the scar tissue  fibers . Fibroblasts have to “patch” the defects remaining after the microneedles. At this point, the  fibroblasts produce collagen islets: the more punctures there are in the skin, the more islands of young collagen are synthesized. Thus, the  fibers of old collagen are destroyed, and in their place new  Fibers are formed, which are already parallel to the surface of the skin and similar in structure to those normally found

 

Antihistamine

Histamine antagonists, particularly those specific to the H1 subtype receptor, can relieve some of the burning and pruritus associated with keloids and may modulate keloid size.The problematic pruritus of keloids probably results
from mast cell degranulation and histamine release. Histamine may also contribute to keloid formation through stimulation of collagen synthesis and other processes.

 

Related Articles

Botox for scars and keloids